Wedbush Cuts Price Target on Stericycle (SRCL) to $82; Reiterates Neutral
- Top 10 News for 12/2: Crude Rips on OPEC Cut; Starbucks' Schultz Steps Down; Nonfarm Payrolls Flat in Nov.
- Unemployment Rate Drops to 4.6%
- Bond yields fall on U.S. jobs data, euro flat before Italy vote
- Alibaba (BABA) Founder Jack Ma Discuss Plans to Retire; 'I Don't Want to Die at the Office'
- Starbucks Coffee (SBUX) CEO Howard Schultz to Step Down, Appointed Executive Chairman; Kevin Johnson New CEO
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Wedbush maintained a Neutral rating on Stericycle (NASDAQ: SRCL), and cut the price target to $82.00 (from $85.00), following the company's investor day. Management clarified the impact from the pricing environment within RMW and specifically the small quantity generator headwinds.
Analyst Al Kaschalk commented, "Despite being forthright with headwinds in the current environment during its investor day, Stericycle’s (SRCL) five-year strategic outlook of calling for organic EPS compounded annual growth rate (CAGR) of 4-8% on sales growth of 3-5% is back-end weighted. Continuous improvement, growth drivers in small healthcare provider segment and acquisitions could add 3-5 percentage points implying EPS CAGR of 7-13% over the forecast period. While the EPS CAGR is generally consistent with the 10-14% we were looking for ahead of the analyst day, annual EPS growth is expected to struggle to exceed 3-4% before mid-CY18. Accordingly, we would avoid shares of SRCL until there is improved pricing environment within core medical waste business, strategic rationale for hazardous waste network (primarily industrial footprint) is completed and International platform enjoys added services to its existing customer base."
Shares of Stericycle closed at $75.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Drexel Hamilton Raises Price Target on Workday (WDAY) Following 3Q Beat
- Jefferies Cuts Price Target on Workday (WDAY) to $71 Following 3Q
- Jefferies Raises Price Target on US Physical Therapy (USPH) to $63 Following 12-Clinic Acquisition
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst PT Change
Related EntitiesAl Kaschalk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!